155 related articles for article (PubMed ID: 17705171)
1. Development of nonsurfactant cyclodextrin nanoparticles loaded with anticancer drug paclitaxel.
Bilensoy E; Gürkaynak O; Ertan M; Sen M; Hincal AA
J Pharm Sci; 2008 Apr; 97(4):1519-29. PubMed ID: 17705171
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery.
Bilensoy E; Gürkaynak O; Doğan AL; Hincal AA
Int J Pharm; 2008 Jan; 347(1-2):163-70. PubMed ID: 17689901
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen citrate loaded amphiphilic beta-cyclodextrin nanoparticles: in vitro characterization and cytotoxicity.
Memisoglu-Bilensoy E; Vural I; Bochot A; Renoir JM; Duchene D; Hincal AA
J Control Release; 2005 Jun; 104(3):489-96. PubMed ID: 15911048
[TBL] [Abstract][Full Text] [Related]
4. The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes.
Ye YJ; Wang Y; Lou KY; Chen YZ; Chen R; Gao F
Int J Nanomedicine; 2015; 10():4309-19. PubMed ID: 26170666
[TBL] [Abstract][Full Text] [Related]
5. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
6. Effect of drug physicochemical properties on in vitro characteristics of amphiphilic cyclodextrin nanospheres and nanocapsules.
Memisoglu-Bilensoy E; Sen M; Hincal AA
J Microencapsul; 2006 Feb; 23(1):59-68. PubMed ID: 16830977
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization and pharmacokinetic studies of tacrolimus-dimethyl-β-cyclodextrin inclusion complex-loaded albumin nanoparticles.
Gao S; Sun J; Fu D; Zhao H; Lan M; Gao F
Int J Pharm; 2012 May; 427(2):410-6. PubMed ID: 22326299
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel loaded nanosponges: in-vitro characterization and cytotoxicity study on MCF-7 cell line culture.
Ansari KA; Torne SJ; Vavia PR; Trotta F; Cavalli R
Curr Drug Deliv; 2011 Mar; 8(2):194-202. PubMed ID: 21235471
[TBL] [Abstract][Full Text] [Related]
9. Hydroxypropyl-β-cyclodextrin-graphene oxide conjugates: Carriers for anti-cancer drugs.
Tan J; Meng N; Fan Y; Su Y; Zhang M; Xiao Y; Zhou N
Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():681-7. PubMed ID: 26838897
[TBL] [Abstract][Full Text] [Related]
10. Stability of paclitaxel-loaded solid lipid nanoparticles in the presence of 2-hydoxypropyl-β-cyclodextrin.
Baek JS; Kim BS; Puri A; Kumar K; Cho CW
Arch Pharm Res; 2016 Jun; 39(6):785-93. PubMed ID: 27146520
[TBL] [Abstract][Full Text] [Related]
11. Direct formation of nanospheres from amphiphilic beta-cyclodextrin inclusion complexes.
Memişoğlu E; Bochot A; Ozalp M; Sen M; Duchêne D; Hincal AA
Pharm Res; 2003 Jan; 20(1):117-25. PubMed ID: 12608545
[TBL] [Abstract][Full Text] [Related]
12. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics.
Chauhan R; Madan J; Kaushik D; Sardana S; Pandey RS; Sharma R
Pharm Dev Technol; 2013; 18(2):313-22. PubMed ID: 21699389
[TBL] [Abstract][Full Text] [Related]
13. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel/beta-cyclodextrin complexes for hyperthermic peritoneal perfusion - formulation and stability.
Bouquet W; Ceelen W; Fritzinger B; Pattyn P; Peeters M; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2007 Jun; 66(3):391-7. PubMed ID: 17240125
[TBL] [Abstract][Full Text] [Related]
15. Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model.
Cırpanlı Y; Allard E; Passirani C; Bilensoy E; Lemaire L; Calış S; Benoit JP
Int J Pharm; 2011 Jan; 403(1-2):201-6. PubMed ID: 20951783
[TBL] [Abstract][Full Text] [Related]
16. Non-surfactant nanospheres of progesterone inclusion complexes with amphiphilic beta-cyclodextrins.
Memişoğlu E; Bochot A; Sen M; Duchêne D; Hincal AA
Int J Pharm; 2003 Jan; 251(1-2):143-53. PubMed ID: 12527184
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel/β-Cyclodextrin interactions, a perspective from pulsed NMR spectroscopy experiments.
Velázquez NS; Ferreyra MG; Mengatto LN; Santagapita PR; Buera MP; Luna JA
Carbohydr Res; 2019 Dec; 486():107828. PubMed ID: 31648123
[TBL] [Abstract][Full Text] [Related]
18. Folate-mediated solid-liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol).
Wu L; Tang C; Yin C
Drug Dev Ind Pharm; 2010 Apr; 36(4):439-48. PubMed ID: 19824865
[TBL] [Abstract][Full Text] [Related]
19. Morphology and in vitro release kinetics of drug-loaded micelles based on well-defined PMPC-b-PBMA copolymer.
Chu H; Liu N; Wang X; Jiao Z; Chen Z
Int J Pharm; 2009 Apr; 371(1-2):190-6. PubMed ID: 19162151
[TBL] [Abstract][Full Text] [Related]
20. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
Jug M; Maestrelli F; Bragagni M; Mura P
J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
